Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 498

1.

Intrarenal mouse renin-angiotensin system during ANG II-induced hypertension and ACE inhibition.

Gonzalez-Villalobos RA, Satou R, Ohashi N, Semprun-Prieto LC, Katsurada A, Kim C, Upchurch GM, Prieto MC, Kobori H, Navar LG.

Am J Physiol Renal Physiol. 2010 Jan;298(1):F150-7. doi: 10.1152/ajprenal.00477.2009. Epub 2009 Oct 21.

2.

Angiotensin-converting enzyme-derived angiotensin II formation during angiotensin II-induced hypertension.

Gonzalez-Villalobos RA, Satou R, Seth DM, Semprun-Prieto LC, Katsurada A, Kobori H, Navar LG.

Hypertension. 2009 Feb;53(2):351-5. doi: 10.1161/HYPERTENSIONAHA.108.124511. Epub 2008 Dec 15.

3.

Intrarenal angiotensin II and angiotensinogen augmentation in chronic angiotensin II-infused mice.

Gonzalez-Villalobos RA, Seth DM, Satou R, Horton H, Ohashi N, Miyata K, Katsurada A, Tran DV, Kobori H, Navar LG.

Am J Physiol Renal Physiol. 2008 Sep;295(3):F772-9. doi: 10.1152/ajprenal.00019.2008. Epub 2008 Jun 25.

4.

Angiotensin II exerts positive feedback on the intrarenal renin-angiotensin system by an angiotensin converting enzyme-dependent mechanism.

Sadjadi J, Kramer GL, Yu CH, Welborn MB 3rd, Modrall JG.

J Surg Res. 2005 Dec;129(2):272-7. Epub 2005 Jun 29.

PMID:
15992826
5.

The renin-angiotensin system and hypertension in autosomal recessive polycystic kidney disease.

Goto M, Hoxha N, Osman R, Dell KM.

Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27.

PMID:
20798958
6.

Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.

Ferrario CM, Jessup J, Gallagher PE, Averill DB, Brosnihan KB, Ann Tallant E, Smith RD, Chappell MC.

Kidney Int. 2005 Nov;68(5):2189-96.

7.

[Up-regulation of intrarenal renin-angiotensin system contributes to renal damage in high-salt induced hypertension rats].

Wu HY, Liang YX, Bai Q, Zhuang Z, A LT, Zheng DX, Wang Y.

Beijing Da Xue Xue Bao. 2015 Feb 18;47(1):149-54. Chinese.

8.

Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats.

Jessup JA, Gallagher PE, Averill DB, Brosnihan KB, Tallant EA, Chappell MC, Ferrario CM.

Am J Physiol Heart Circ Physiol. 2006 Nov;291(5):H2166-72. Epub 2006 Jun 9.

9.

Dual RAS blockade normalizes angiotensin-converting enzyme-2 expression and prevents hypertension and tubular apoptosis in Akita angiotensinogen-transgenic mice.

Lo CS, Liu F, Shi Y, Maachi H, Chenier I, Godin N, Filep JG, Ingelfinger JR, Zhang SL, Chan JS.

Am J Physiol Renal Physiol. 2012 Apr 1;302(7):F840-52. doi: 10.1152/ajprenal.00340.2011. Epub 2011 Dec 28.

10.

Aberrant activation of the intrarenal renin-angiotensin system in the developing kidneys of type 2 diabetic rats.

Fan YY, Kobori H, Nakano D, Hitomi H, Mori H, Masaki T, Sun YX, Zhi N, Zhang L, Huang W, Zhu B, Li P, Nishiyama A.

Horm Metab Res. 2013 May;45(5):338-43. doi: 10.1055/s-0032-1331256. Epub 2013 Jan 15.

11.

Primacy of angiotensin converting enzyme in angiotensin-(1-12) metabolism.

Moniwa N, Varagic J, Simington SW, Ahmad S, Nagata S, Voncannon JL, Ferrario CM.

Am J Physiol Heart Circ Physiol. 2013 Sep 1;305(5):H644-50. doi: 10.1152/ajpheart.00210.2013. Epub 2013 Jun 28.

12.

Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.

Husková Z, Kopkan L, Červenková L, Doleželová Š, Vaňourková Z, Škaroupková P, Nishiyama A, Kompanowska-Jezierska E, Sadowski J, Kramer HJ, Červenka L.

Clin Exp Pharmacol Physiol. 2016 Apr;43(4):438-49. doi: 10.1111/1440-1681.12553.

PMID:
26833491
13.

Sex differences in the pressor response to angiotensin II when the endogenous renin-angiotensin system is blocked.

Sartori-Valinotti JC, Iliescu R, Yanes LL, Dorsett-Martin W, Reckelhoff JF.

Hypertension. 2008 Apr;51(4):1170-6. doi: 10.1161/HYPERTENSIONAHA.107.106922. Epub 2008 Feb 7.

14.

Divergent pathways for the angiotensin-(1-12) metabolism in the rat circulation and kidney.

Westwood BM, Chappell MC.

Peptides. 2012 Jun;35(2):190-5. doi: 10.1016/j.peptides.2012.03.025. Epub 2012 Apr 3.

15.

Reciprocal changes in renal ACE/ANG II and ACE2/ANG 1-7 are associated with enhanced collecting duct renin in Goldblatt hypertensive rats.

Prieto MC, González-Villalobos RA, Botros FT, Martin VL, Pagán J, Satou R, Lara LS, Feng Y, Fernandes FB, Kobori H, Casarini DE, Navar LG.

Am J Physiol Renal Physiol. 2011 Mar;300(3):F749-55. doi: 10.1152/ajprenal.00383.2009. Epub 2011 Jan 5.

16.

Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: I. Effects on left ventricular performance and neurohormonal systems.

Spinale FG, de Gasparo M, Whitebread S, Hebbar L, Clair MJ, Melton DM, Krombach RS, Mukherjee R, Iannini JP, O SJ.

Circulation. 1997 Oct 7;96(7):2385-96.

17.

The intrarenal renin-angiotensin system in hypertension.

Carey RM.

Adv Chronic Kidney Dis. 2015 May;22(3):204-10. doi: 10.1053/j.ackd.2014.11.004. Review.

PMID:
25908469
18.

Urinary angiotensinogen as a potential biomarker of intrarenal renin-angiotensin system activity in Chinese chronic kidney disease patients.

Xu Z, Xu B, Xu C.

Ir J Med Sci. 2015 Jun;184(2):297-304. doi: 10.1007/s11845-014-1103-6. Epub 2014 Mar 25.

PMID:
24664631
19.

ELISA examining urinary angiotensinogen as a potential indicator of intrarenal renin-angiotensin system (RAS) activity: a clinical study of 128 chronic kidney disease patients.

Zhang XY, Ding XQ, Lv WL, Teng J, Zhong YH.

Mol Biol Rep. 2013 Oct;40(10):5817-24. doi: 10.1007/s11033-013-2687-z. Epub 2013 Sep 25.

PMID:
24065527
20.

Renal protective effects of blocking the intrarenal renin-angiotensin system.

Li J, Zhou C, Yu L, Wang H.

Hypertens Res. 1999 Sep;22(3):223-8.

Supplemental Content

Support Center